Quick Answer
XTL BIOPHARMACEUTICALS LTD reported Gross Profit of $3.0 thousand for the year ending 2024.
- This data is from XTL BIOPHARMACEUTICALS LTD's annual report (Form 10-K), filed with the SEC on April 30, 2025.
- XBRL data for this metric is available from 2024 to 2024 (1 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: